Many parallels exist between growth and development of the placenta and that of cancer. One parallel is shared expression of antigens that may have functional importance and may be recognized by the immune system. Here, we characterize expression and regulation of one such antigen, Trophoblast glycoprotein (TPGB; also called 5T4), in the placenta across gestation, in placentas of preeclamptic (PE) pregnancies, and in purified microvesicles and exosomes.
Methods:
Trophoblast glycoprotein expression was analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry. Regulation of 5T4 in cytotrophoblast cells was examined under either differentiating conditions of epidermal growth factor or under varying oxygen conditions. Microvesicles and exosomes were purified from supernatant of cultured and perfused placentas.
Results:
Trophoblast glycoprotein expression was prominent at the microvillus surface of syncytiotrophoblast and on the extravillous trophoblast cells, with minimal expression in undifferentiated cytotrophoblasts and normal tissues. Trophoblast glycoprotein expression was elevated in malignant tumors. In cytotrophoblasts, 5T4 was induced by in vitro differentiation, and its messenger RNA (mRNA) was increased under conditions of low oxygen. PE placentas expressed higher 5T4 mRNA than matched control placentas. Trophoblast glycoprotein was prominent within shed placental microvesicles and exosomes.
Conclusion:
Given the potential functional and known immunological importance of 5T4 in cancer, these studies reveal a class of proteins that may influence placental development and/or sensitize the maternal immune system. In extravillous trophoblasts, 5T4 may function in epithelial-to-mesenchymal transition during placentation. The role of syncytiotrophoblast 5T4 is unknown, but its abundance in shed syncytial vesicles may signify route of sensitization of the maternal immune system.
PijnenborgRDixonGRobertsonWBBrosensI. Trophoblast invasion of human decidua from 8-18 weeks of pregnancy. Placenta. 1980;1(1):3–19.
2.
HarrisLKAplinJD. Vascular remodeling and extracellular matrix breakdown in the uterine spiral arteries during pregnancy. Reprod Sci. 2007;14(suppl 8):28–34.
3.
BulmerJNInnesBALeveyJRobsonSCLashGE. The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy. FASEB J. 2012;26(7):2975–2985.
4.
PijnenborgRRobertsonWBBrosnensIDixonG. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta. 1981;2(1):71–91.
5.
MurrayMJLesseyBA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol. 1999;17(3):275–290.
6.
StricklandSRichardsWG. Invasion of the trophoblasts. Cell. 1992;71(3):355–357.
7.
PerryJKLinsRJLobiePEMitchellMD. Regulation of invasive growth: similar epigenetic mechanisms underpin tumor progression and implantation in human pregnancy. Clin Sci (Lond). 2010;118(7):451–457.
8.
JordanNVJohnsonGLAbellAN. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle. 2011;10(17):2865–2873.
9.
WilczynskiJR. Cancer and pregnancy share similar mechanisms of immunological escape. Chemotherapy. 2006;52(3):107–110.
10.
JungbluthAASilvaWAJrIversenK. Expression of cancer-testis (CT) antigens in placenta. Cancer Immun. 2007;7:15.
11.
KoslowskiMSahinUMitnacht-KrausRSeitzGHuberCTüreciO. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res. 2007;67(19):9528–9534.
12.
ButterfieldLH. Cancer vaccines. BMJ. 2015;350:h988.
13.
HoleNSternPL. A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer. 1988;57(3):239–246.
14.
KingKWSheppardFCWestwaterCSternPLMyersKA. Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues. Biochim Biophys Acta. 1999;1445(3):257–270.
15.
MyersKARahi-SaundVDavisonMDYoungJACheaterAJSternPL. Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem. 1994;269(12):9319–9324.
16.
KobeBKajavaAV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001;11(6):725–732.
17.
AwanALucicMRShawDM. 5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis. Biochem Biophys Res Commun. 2002;290(3):1030–1036.
18.
CarsbergCJMyersKASternPL. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer. 1996;68(1):84–92.
19.
Kagermeier-SchenkBWehnerDÖzhan-KizilG. Waif1/5T4 inhibits Wnt/β-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization. Devel Cell. 2011;21(6):1129–1143.
20.
MitchellPJWeltonJStaffurthJ. Can urinary exosomes act as treatment response markers in prostate cancer?J Transl Med. 2009;7:4.
21.
PetroffMGPhillipsTAKaHPaceJLHuntJS. Isolation and culture of term human trophoblast cells. Methods Mol Med. 2006;121:203–217.
22.
HoletsLMCarlettiMZKshirsagarSKChristensonLKPetroffMG. Differentiation-induced post-transcriptional control of B7-H1 in human trophoblast cells. Placenta. 2009;30(1):48–55.
23.
GrahamCHHawleyTSHawleyRG. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 1993;206(2):204–211.
24.
Straszewski-ChavezSLAbrahamsVMAlveroAB. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta. 2009;30(11):939–948.
25.
TheryCAmigorenaSRaposoGClaytonA. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3 22.
26.
KshirsagarSKAlamSMJastiS. Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta. 2012;33(12):982–990.
27.
DragovicRAGardinerCBrooksAS. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011;7(6):780–788.
28.
DragovicRACollettGPHoleP. Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence Nanoparticle Tracking Analysis. Methods. 2015;87:64–74.
29.
HoletsLMHuntJSPetroffMG. Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol Reprod. 2006;74(2):352–358.
30.
LinscheidCHeitmannESinghP. Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women. Placenta. 2015;36(8):832–838.
31.
MorrishDWBhardwajDDabbaghLKMarusykHSiyO. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab. 1987;65(6):1282–1290.
32.
MorrishDWDakourJLiH. Functional regulation of human trophoblast differentiation. J Reprod Immunol. 1998;39(1-2):179–195.
33.
JaffeRJauniauxEHustinJ. Maternal circulation in the first-trimester human placenta—myth or reality?Am J Obstet Gynecol. 1997;176(3):695–705.
34.
CarsbergCJMyersKAEvansGSAllenTDSternPL. Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci. 1995;108(pt 8):2905–2916.
35.
RobertsJMEscuderoC. The placenta and preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83.
36.
RaposoGNijmanHWStoorvogelW. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161–1172.
37.
HoleNSternPL. Isolation and characterization of 5T4, a tumor-associated antigen. Int J Cancer. 1990;45(1):179–184.
38.
SouthallPJBoxerGMBagshaweKDHoleNBromleyMSternPL. Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer. 1990;61(1):89–95.
39.
KokkinosMIMurthiPWafaiRThompsonEWNewgreenDF. Cadherins in the human placenta—epithelial–mesenchymal transition (EMT) and placental development. Placenta. 2010;31(9):747–755.
40.
SouthgateTDMcGinnOJCastroFV. CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells. PLoS One. 2010;5(4):e9982.
41.
McGinnOJMarinovGSawanSSternPL. CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein. J Cell Sci. 2012;125(pt 22):5467–5478.
42.
ZhaoYMalinauskasTHarlosKJonesEY. Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wnt-activated inhibitory factor 1. Structure. 2014;22(4):612–620.
43.
SchanzABaston-BustDKrusselJSHeissCJanniWHessAP. CXCR7 and syndecan-4 are potential receptors for CXCL12 in human cytotrophoblasts. J Reprod Immunol. 2011;89(1):18–25.
44.
SchanzARed-HorseKHessAPBaston-BüstDMHeissCKrüsselJS. Oxygen regulates human cytotrophoblast migration by controlling chemokine and receptor expression. Placenta. 2014;35(12):1089–1094.
45.
PollheimerJLoreggerTSondereggerS. Activation of the canonical wingless/T-Cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol. 2006;168(4):1134–1147.
46.
JauniauxEWatsonALHempstockJBaoYPSkepperJNBurtonGJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157(6):2111–2122.
47.
NelsonDMJohnsonRDSmithSDAntebyEYSadovskyY. Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. Am J Obstet Gynecol. 1999;180(4):896–902.
48.
WeltonJLKhannaSGilesPJ. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010;9(6):1324–1338.
49.
StenqvistACNagaevaOBaranovVMincheva-NilssonL. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol. 2013;191(11):5515–5523.
50.
TaylorDDAkyolSGercel-TaylorC. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol. 2006;176(3):1534–1542.
51.
WolfersJLozierARaposoG. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297–303.
52.
ErlebacherAVencatoDPriceKAZhangDGlimcherLH. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest. 2007;117(5):1399–1411.
53.
MoldenhauerLMDienerKRThringDMBrownMPHayballJDRobertsonSA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol. 2009;182(12):8080–8093.
54.
AbumareeMHStonePRChamleyLW. The effects of apoptotic, deported human placental trophoblast on macrophages: Possible consequences for pregnancy. J Reprod Immunol. 2006;72(1-2):33–45.
